Product Image
Please see full prescribing and safety information, including boxed warning, for CIPROFLOXACIN bags. PACKAGE INSERT | MEDICATION GUIDE

Available in:

  • 200 mg per 100 mL in 5% Dextrose premix bags
  • 400 mg per 200 mL in 5% Dextrose premix bags

Benefits:

  • AP Rated
  • Preservative-free
  • Not made with natural rubber latex

CIPROFLOXACIN Injection, USP*

Brand Name Equivalent: CIPRO® (CIPRO is a registered trademark of Bayer Aktiengesellschaft Joint Stock Company)
Therapeutic Category: Anti-infective / Antibiotic

PreventIV MeasuresTM Features:

  • Easy-to-read drug name and dosage strength to aid in identifying the right product
  • Drug name and strength printed on front and back of overwrap
  • Unique label design to help products stand out on the shelf
  • Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
NDC
#25021
Description Strength Fill
Volume
Concentration Container
Size
Closure Unit
of Sale
114-82 Premix Bag 200 mg 100 mL 2 mg per mL N/A N/A 24
114-87 Premix Bag 400 mg 200 mL 2 mg per mL N/A N/A 24
WARNING:TENDON EFFECTS and MYASTHENIA GRAVIS
Fluoroquinolones, including CIPROFLOXACIN INJECTION, USP, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants [see Warnings and Precautions (5.1)].

Fluoroquinolones, including CIPROFLOXACIN INJECTION, USP, may exacerbate muscle weakness in persons with myasthenia gravis. Avoid CIPROFLOXACIN INJECTION, USP in patients with known history of myasthenia gravis [see Warnings and Precautions (5.2)].